Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes at Two Years after VITAL Trial Completion.
Karen H CostenbaderMitchell H GailI-Min LeeJill HahnJoseph WalterVadim BubesGregory KotlerNicole YangSonia FriedmanErik K AlexanderJoAnn E MansonPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2024)
Two years after trial termination, vitamin D 2000 IU/day's protective effects dissipated, but 1000 mg/day n-3 fatty acids had a sustained effect in reducing AD incidence.